Estimated burden of serious human fungal diseases in Turkey

dc.contributor.authorHilmioğlu-Polat S.
dc.contributor.authorSeyedmousavi S.
dc.contributor.authorIlkit M.
dc.contributor.authorHedayati M.T.
dc.contributor.authorInci R.
dc.contributor.authorTumbay E.
dc.contributor.authorDenning D.W.
dc.date.accessioned2019-10-26T21:14:06Z
dc.date.available2019-10-26T21:14:06Z
dc.date.issued2019
dc.departmentEge Üniversitesien_US
dc.description.abstractThe current number of fungal infections occurring each year in Turkey is unknown. We estimated the burden of serious human fungal diseases based on the population at risk, existing epidemiological data from 1920 to 2017 and modelling previously described by the LIFE program (http://www.LIFE-worldwide.org). Among the population of Turkey (80.8 million in 2017), approximately 1 785 811 (2.21%) people are estimated to suffer from a serious fungal infection each year. The model used predicts high prevalences of allergic fungal rhinosinusitis episodes (312 994 cases) (392/100 000), of severe asthma with fungal sensitisation (42 989 cases) (53.20 cases/100 000 adults per year), of allergic bronchopulmonary aspergillosis (32 594 cases) (40.33/100 000), of fungal keratitis (26 671 cases) (33/100 000) and of chronic pulmonary aspergillosis (5890 cases) (7.29/100 000). The estimated annual incidence for invasive aspergillosis is lower (3911 cases) (4.84/100 000 annually). Among about 22.5 million women aged 15-50 years, recurrent vulvovaginal candidiasis is estimated to occur in 1 350 371 (3342/100 000) females. The burden of three superficial fungal infections was also estimated: tinea pedis (1.79 million), tinea capitis (43 900) and onychomycosis (1.73 million). Given that the modelling estimates reported in the current study might be substantially under- or overestimated, formal epidemiological and comprehensive surveillance studies are required to validate or modify these estimates. © 2018 Blackwell Verlag GmbHen_US
dc.description.sponsorshipNational Institutes of Health National Institute of Allergy and Infectious Diseases National Institutes of Health Juvenile Diabetes Research Foundation United States of America National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health National Institute of Allergy and Infectious Diseases National Institutes of Healthen_US
dc.description.sponsorship2Molecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States of America -- Seyedmojtaba Seyedmousavi, Molecular Microbiology Section, Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD. Email: Seyedmousavi@nih.gov -- S.S. is presently supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. All the other authors declare no conflict of interests related to this publication. --en_US
dc.identifier.doi10.1111/myc.12842
dc.identifier.endpage31en_US
dc.identifier.issn0933-7407
dc.identifier.issn0933-7407en_US
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage22en_US
dc.identifier.urihttps://doi.org/10.1111/myc.12842
dc.identifier.urihttps://hdl.handle.net/11454/15836
dc.identifier.volume62en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherBlackwell Publishing Ltden_US
dc.relation.ispartofMycosesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcandidiasisen_US
dc.subjectinvasive aspergillosisen_US
dc.subjectrecurrent Candida vaginitisen_US
dc.subjectserious fungal infectionen_US
dc.subjectsevere asthma with fungal sensitisationen_US
dc.subjectTurkeyen_US
dc.titleEstimated burden of serious human fungal diseases in Turkeyen_US
dc.typeArticleen_US

Dosyalar